Back
Entrada Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
64
TRDA
Entrada Therapeutics
Last Price:
19.01
Seasonality Move:
-34.31%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.5 | Buy |
| 20-day SMA: | 17.19 | Buy |
| 50-day SMA: | 16.25 | Buy |
| 200-day SMA: | 14.96 | Buy |
| 8-day EMA: | 17.65 | Buy |
| 20-day EMA: | 17.18 | Buy |
| 50-day EMA: | 16.55 | Buy |
| 200-day EMA: | 15.47 | Buy |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 68.97 | Buy |
| Chaikin Money Flow: | 153692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.42 - 17.68) | Buy |
| Bollinger Bands (100): | (14.77 - 17.19) | Buy |
Entrada Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 18.62 while TRDA 8-day simple moving average is 17.50, which is a Buy signal.
- The stock price of TRDA is 18.62 while Entrada Therapeutics 20-day SMA is 17.19, which makes it a Buy.
- Entrada Therapeutics 50-day simple moving average is 16.25 while TRDA share price is 18.62, making it a Buy technically.
- TRDA stock price is 18.62 and Entrada Therapeutics 200-day simple moving average is 14.96, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
64
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Buy
The current Entrada Therapeutics [TRDA] share price is $18.62. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
692.66M
Price in USD:
18.62
Share Volume:
153.69K
Entrada Therapeutics 52-Week Range
52-Week High:
18.62
52-Week Low:
10.75
Buy
64
Entrada Therapeutics (TRDA)
is a Buy
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 18.62 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is not overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 18.62 while TRDA 8-day exponential moving average is 17.65, which is a Buy signal.
- The stock price of TRDA is 18.62 while Entrada Therapeutics 20-day EMA is 17.18, which makes it a Buy.
- Entrada Therapeutics 50-day exponential moving average is 16.55 while TRDA share price is 18.62, making it a Buy technically.
- TRDA stock price is 18.62 and Entrada Therapeutics 200-day simple moving average is 15.47, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Entrada Therapeutics is a Buy
- Entrada Therapeutics Relative Strength Index (RSI) is 68.97, which suggest Entrada Therapeutics is overbought
- The Bollinger Bands (25) for Entrada Therapeutics is (16.42 - 17.68), which suggest Entrada Therapeutics is a Buy
- The Bollinger Bands (100) for Entrada Therapeutics is (14.77 - 17.19), which suggest Entrada Therapeutics is a Buy
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.